Pharming Group N.V.
PHARM.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€10,947 | -€12,012 | €14,987 | €22,032 |
| Dep. & Amort. | €15,512 | €15,925 | €13,188 | €18,721 |
| Deferred Tax | €0 | €0 | €0 | -€721 |
| Stock-Based Comp. | €10,858 | €9,251 | €6,392 | €9,056 |
| Change in WC | -€7,050 | -€16,961 | -€387 | -€4,735 |
| Other Non-Cash | -€10,169 | -€13,505 | -€11,283 | -€7,817 |
| Operating Cash Flow | -€1,733 | -€17,302 | €22,897 | €36,126 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€736 | -€1,464 | -€1,977 | -€15,958 |
| Net Acquisitions | €0 | €0 | €7,300 | €0 |
| Inv. Purchases | -€262,842 | -€382,014 | €0 | -€4,381 |
| Inv. Sales/Matur. | €292,808 | €232,811 | €0 | €0 |
| Other Inv. Act. | €2,388 | €21,279 | €6,256 | -€0 |
| Investing Cash Flow | €31,618 | -€129,388 | €5,323 | -€20,338 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€34,393 | -€4,643 | -€3,092 | -€2,826 |
| Stock Issued | €5,158 | €0 | €2,281 | €4,718 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | -€5,177 | €3,604 | -€4,171 | -€29,839 |
| Financing Cash Flow | -€34,412 | -€1,039 | -€4,982 | -€26,679 |
| Forex Effect | -€2,208 | €1,928 | -€7,820 | €13,458 |
| Net Chg. in Cash | -€6,797 | -€145,601 | €15,418 | €2,567 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €61,741 | €207,342 | €191,924 | €189,158 |
| End Cash | €54,944 | €61,741 | €207,342 | €191,725 |
| Free Cash Flow | -€2,495 | -€18,766 | €20,920 | €20,168 |